Código QR (código de barras bidimensional)

Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström Macroglobulinemia

Waldenström macroglobulinemia (WM) is a rare form of non-Hodgkin B-cell lymphoma with a variable clinical presentation that can impact a patient’s quality of life by causing anemia, peripheral neuropathy, serum hyperviscosity, extramedullary disease, and other symptoms. There are several safe and ef...

Fuld beskrivelse

Na minha lista:
Principais autores: Javier Muñoz, Jonas Paludo, Shayna Sarosiek, Jorge J. Castillo
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2022-10-01
Serier:Cells
Fag:
Waldenström macroglobulinemia
zanubrutinib
Bruton tyrosine kinase inhibitor
costs
combination therapy
Online adgang:https://www.mdpi.com/2073-4409/11/20/3287
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker